Boothbay Fund Management, LLC Aurinia Pharmaceuticals Inc. Transaction History

Boothbay Fund Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$7.13 - $9.49 $1,162 - $1,546	-163 Reduced 1.15%	14,000 $125,000
Q3 2023 Nov 14, 2023	BUY	$7.77 - $12.27 $110,046 - $173,780	14,163 New	14,163 $110,000
Q3 2020 Nov 16, 2020	SELL	$13.19 - $16.66 $470,065 - $593,729	-35,638 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$14.12 - $18.33 $1,948 - $2,529	138 Added 0.39%	35,638 $579,000
Q1 2020 May 15, 2020	SELL	$11.34 - $21.46 $571,853 - $1.08 Million	-50,428 Reduced 58.69%	35,500 $515,000
Q4 2019 Feb 14, 2020	BUY	$3.88 - $21.42 $333,400 - $1.84 Million	85,928 New	85,928 $1.74 Million
Q2 2019 Aug 14, 2019	SELL	$6.05 - $6.75 $484,000 - $540,000	-80,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$6.06 - $7.64 $484,799 - $611,200	80,000 New	80,000 $520,000
Q4 2018 Feb 14, 2019	SELL	$5.08 - $6.83 $395,798 - $532,145	-77,913 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.27 - $6.64 $220,881 - $278,302	41,913 Added 116.43%	77,913 $517,000
Q2 2018 Aug 14, 2018	BUY	$5.06 - $6.36 $182,160 - $228,960	36,000 New	36,000 $203,000
Q4 2017 Feb 14, 2018	SELL	$4.53 - $7.09 $57,648 - $90,227	-12,726 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.71 - $6.9 $72,665 - $87,809	12,726	12,726 $80,000

209

58.7M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.